文献速递创伤骨科骨质疏松与代谢性骨病

加拿大安大略省精神分裂症成人髋部骨折后骨质疏松管理:一项为期10年的基于人群的回顾性队列研究

Osteoporosis management in adults with schizophrenia following index hip fracture event: a 10-year population-based retrospective cohort study, Ontario, Canada.
PubMed 文献 · Osteoporos Int · 2024-05-17

该研究基于加拿大安大略省2009至2018财年健康行政数据库,纳入52722例66至105岁髋部骨折患者,其中1890例(3.6%)患有精神分裂症。采用Fine-Gray竞争风险模型(以死亡为竞争事件)分析发现,精神分裂症与较低的骨质疏松检测或治疗复合结局发生率相关(0.795(0.721,0.877))。作者认为需进一步研究该弱势人群骨质疏松管理的障碍。

要点

  • 髋部骨折患者中精神分裂症患者较无精神分裂症者更常见于长期护理机构(44.3% vs 18.1%)。
  • 精神分裂症与较低的骨质疏松检测或治疗复合结局发生率相关(0.795(0.721,0.877))。
  • 作者认为需进一步研究该弱势人群骨质疏松管理的障碍。

核心结论

  • 在这项基于人群的回顾性队列研究中,髋部骨折患者中精神分裂症诊断与较低的检测或治疗发生率相关,该分析已考虑死亡及若干促成和易感因素。
  • 作者认为需进一步研究该弱势人群骨质疏松管理的障碍。

研究设计与样本

  • 回顾性基于人群的队列研究,利用健康行政数据库,纳入加拿大安大略省2009至2018财年66至105岁髋部骨折个体。
  • 精神分裂症采用经验证的算法确定。
  • 结局为复合指标:(1)骨质疏松药物处方;或(2)骨密度(BMD)检测。
  • 采用Fine-Gray子分布风险回归进行推断分析,以死亡为竞争事件。

主要发现

  • 共识别52722例66至105岁在研究期间发生首次髋部骨折的个体,其中1890例(3.6%)患有精神分裂症。
  • 髋部骨折患者中,有精神分裂症者较无精神分裂症者更可能为长期护理机构居民(44.3% vs 18.1%;标准化差0.59)。
  • 有精神分裂症者较无精神分裂症者更可能衰弱(62.5% vs 36.5%;标准化差0.54)。
  • 有精神分裂症者较无精神分裂症者更可能无初级保健提供者(9.2% vs 4.8%;标准化差0.18)。
  • 在Fine-Gray模型中,精神分裂症与较低的检测或治疗发生率相关(0.795(0.721,0.877))。

局限性

  • 作者认为需进一步研究该弱势人群骨质疏松管理的障碍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Little is known about the incidence of osteoporosis testing and treatment in individuals with schizophrenia, who may be more likely to fracture. Using competing risk models, we found that schizophrenia was associated with lower incidence of testing or treatment. Implications are for understanding barriers and solutions for this disadvantaged group. PURPOSE: Evidence suggests that individuals with schizophrenia may be more likely to experience hip fractures than the general population; however, little is known about osteoporosis management in this disadvantaged subpopulation. Our study objective was to compare bone mineral density (BMD) testing and pharmacologic treatment in hip fracture patients with versus without schizophrenia. METHODS: This was a retrospective population-based cohort study leveraging health administrative databases, and individuals aged 66-105 years with hip fracture between fiscal years 2009 and 2018 in Ontario, Canada. Schizophrenia was ascertained using a validated algorithm. The outcome was a composite measure of (1) pharmacologic prescription for osteoporosis; or (2) a BMD test. Inferential analyses were conducted using Fine-Gray subdistribution hazard regression, with mortality as the competing event. RESULTS: A total of 52,722 individuals aged 66 to 105 years who sustained an index hip fracture in Ontario during the study period were identified, of whom 1890 (3.6%) had schizophrenia. Hip fracture patients with vs without schizophrenia were more likely to be long-term care residents (44.3% vs. 18.1%; standardized difference, 0.59), frail (62.5% vs. 36.5%; standardized difference, 0.54) and without a primary care provider (9.2% vs. 4.8%; standardized difference, 0.18). In Fine-Gray models, schizophrenia was associated with a lower incidence of testing or treatment (0.795 (0.721, 0.877)). CONCLUSIONS: In this population-based retrospective cohort study, a schizophrenia diagnosis among hip fracture patients was associated with a lower incidence of testing or treatment, after accounting for mortality, and several enabling and predisposing factors. Further research is required to investigate barriers to osteoporosis management in this disadvantaged population.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Ansari H, Jaglal S, Cheung AM, et al. Osteoporosis management in adults with schizophrenia following index hip fracture event: a 10-year population-based retrospective cohort study, Ontario, Canada. Osteoporos Int. 2024. PMID: 38760503. doi:10.1007/s00198-024-07123-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。